Literature DB >> 27562494

ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions.

Sophie Le Guellec1,2, Valérie Velasco3, Gaëlle Pérot2,3, Sarah Watson4, Franck Tirode4, Jean-Michel Coindre2,3,5.   

Abstract

Subsets of primitive round-cell sarcomas remain difficult to diagnose and classify. Among these is a rare round-cell sarcoma that harbors a CIC gene rearrangement known as CIC-rearranged undifferentiated round-cell sarcoma, which is most commonly fused to the DUX4 gene. Owing to its aggressive clinical behavior and potential therapeutic implications, accurate identification of this novel soft tissue sarcoma is necessary. Definitive diagnosis requires molecular confirmation, but only a few centers are as yet able to perform this test. Several studies have shown that PEA3 subfamily genes, notably ETV4 (belonging to the family of ETS transcription factors), are upregulated in CIC-rearranged undifferentiated round-cell sarcomas. We performed a detailed immunohistochemical analysis to investigate ETV4 expression in CIC-rearranged undifferentiated round-cell sarcomas and their potential mimics (especially Ewing sarcomas). The study cohort included 17 cases of CIC-rearranged undifferentiated round-cell sarcomas, and 110 tumors that morphologically mimic CIC-rearranged undifferentiated round-cell sarcomas: 43 Ewing sarcomas, 25 alveolar rhabdomyosarcomas, 20 poorly differentiated round-cell synovial sarcomas, 10 desmoplastic round-cell tumors, 5 BCOR-CCNB3 sarcomas, 5 lymphoblastic lymphomas, and 2 rhabdoid tumors. All CIC-rearranged undifferentiated round-cell sarcomas (on core needle biopsies and open biopsies) were ETV4-positive with a strong diffuse nuclear pattern. Among the other 110 tumors, only six cases (four Ewing sarcomas, one alveolar rhabdomyosarcoma, and one desmoplastic round-cell tumor) showed focal (<5% of tumor cells) and very weak nuclear expression of ETV4; all other tumors were completely negative for ETV4. We conclude that systematic immunohistochemical analysis of ETV4 makes it possible to diagnose undifferentiated round-cell sarcomas (with no molecular markers for sarcoma-associated translocation) such as CIC-rearranged undifferentiated round-cell sarcoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27562494     DOI: 10.1038/modpathol.2016.155

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

1.  High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.

Authors:  Antoine Italiano; Yun Shao Sung; Lei Zhang; Samuel Singer; Robert G Maki; Jean-Michel Coindre; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2011-11-10       Impact factor: 5.006

2.  Translocation (4;19)(q35;q13.1)-associated primitive round cell sarcoma: report of a case and review of the literature.

Authors:  Dinesh Rakheja; Stanton Goldman; Kathleen S Wilson; Carl Lenarsky; Joel Weinthal; Roger A Schultz
Journal:  Pediatr Dev Pathol       Date:  2007-07-16

Review 3.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

4.  Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology.

Authors:  Eun-Young Karen Choi; Dafydd G Thomas; Jonathan B McHugh; Rajiv M Patel; Diane Roulston; Scott M Schuetze; Rashmi Chugh; Janet Sybil Biermann; David R Lucas
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

5.  CIC-rearranged Sarcomas: A Study of 20 Cases and Comparisons With Ewing Sarcomas.

Authors:  Akihiko Yoshida; Keisuke Goto; Makoto Kodaira; Eisuke Kobayashi; Hiroshi Kawamoto; Taisuke Mori; Seiichi Yoshimoto; Otone Endo; Narihito Kodama; Ryoji Kushima; Nobuyoshi Hiraoka; Toru Motoi; Akira Kawai
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

6.  Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.

Authors:  Miho Kawamura-Saito; Yukari Yamazaki; Keiko Kaneko; Noriyoshi Kawaguchi; Hiroaki Kanda; Hiroyuki Mukai; Takahiro Gotoh; Tohru Motoi; Masashi Fukayama; Hiroyuki Aburatani; Toichiro Takizawa; Takuro Nakamura
Journal:  Hum Mol Genet       Date:  2006-05-22       Impact factor: 6.150

7.  Clinicopathologic features of a second patient with Ewing-like sarcoma harboring CIC-FOXO4 gene fusion.

Authors:  David A Solomon; Andrew S Brohl; Javed Khan; Markku Miettinen
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

8.  Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.

Authors:  Katja Specht; Yun-Shao Sung; Lei Zhang; Günther H S Richter; Christopher D Fletcher; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2014-04-10       Impact factor: 5.006

9.  A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma.

Authors:  Shintaro Sugita; Yasuhito Arai; Akiko Tonooka; Natsuko Hama; Yasushi Totoki; Tomoki Fujii; Tomoyuki Aoyama; Hiroko Asanuma; Tomohide Tsukahara; Mitsunori Kaya; Tatsuhiro Shibata; Tadashi Hasegawa
Journal:  Am J Surg Pathol       Date:  2014-11       Impact factor: 6.394

10.  Primary subcutaneous primitive neuroectodermal tumor with aggressive behavior and an unusual karyotype: case report.

Authors:  Gino R Somers; Mary Shago; Maria Zielenska; Helen S L Chan; Bo Y Ngan
Journal:  Pediatr Dev Pathol       Date:  2004-10-06
View more
  27 in total

1.  CIC-DUX4 Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma.

Authors:  Toyoki Yoshimoto; Miwa Tanaka; Mizuki Homme; Yukari Yamazaki; Yutaka Takazawa; Cristina R Antonescu; Takuro Nakamura
Journal:  Cancer Res       Date:  2017-04-12       Impact factor: 12.701

2.  Metastasis: From head to tail.

Authors:  Ross A Okimoto; Trever G Bivona
Journal:  Cell Cycle       Date:  2017-01-05       Impact factor: 4.534

3.  Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.

Authors:  Cristina R Antonescu; Adepitan A Owosho; Lei Zhang; Sonja Chen; Kemal Deniz; Joseph M Huryn; Yu-Chien Kao; Shih-Chiang Huang; Samuel Singer; William Tap; Inga-Marie Schaefer; Christopher D Fletcher
Journal:  Am J Surg Pathol       Date:  2017-07       Impact factor: 6.394

4.  CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.

Authors:  Ross A Okimoto; Wei Wu; Shigeki Nanjo; Victor Olivas; Yone K Lin; Rovingaile Kriska Ponce; Rieko Oyama; Tadashi Kondo; Trever G Bivona
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 14.808

Review 5.  Ewing sarcoma and Ewing-like tumors.

Authors:  Marta Sbaraglia; Alberto Righi; Marco Gambarotti; Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2019-12-04       Impact factor: 4.064

6.  Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.

Authors:  Yin P Hung; Christopher Dm Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

Review 7.  [Ewing sarcomas and Ewing-like sarcomas : New aspects].

Authors:  K Specht; W Hartmann
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

8.  Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic Differentiation.

Authors:  Abhijit Chougule; Martin S Taylor; Valentina Nardi; Ivan Chebib; Gregory M Cote; Edwin Choy; G Petur Nielsen; Vikram Deshpande
Journal:  Am J Surg Pathol       Date:  2019-02       Impact factor: 6.394

Review 9.  Immunohistochemical Biomarkers of Mesenchymal Neoplasms in Endocrine Organs: Diagnostic Pitfalls and Recent Discoveries.

Authors:  Yin P Hung; Jason L Hornick
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

10.  ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control.

Authors:  Joanna DeSalvo; Yuguang Ban; Luyuan Li; Xiaodian Sun; Zhijie Jiang; Darcy A Kerr; Mahsa Khanlari; Maria Boulina; Mario R Capecchi; Juha M Partanen; Lin Chen; Tadashi Kondo; David M Ornitz; Jonathan C Trent; Josiane E Eid
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.